References
Aiken, J. (2001). “City Targets Illegal Prescription Drug Trade.” [
Full Text ]
Alliance of States With Prescription Monitoring Programs (1999). The Goals of Prescription Monitoring. Waltham, Mass.: Alliance of States With Prescription Monitoring Programs. [
Full Text ]
Clarke, R. (ed.) ( 1997). Situational Crime Prevention: Successful Case Studies (2nd ed.). Albany, N.Y.: Harrow and Heston.
Community Antidrug Coalitions of America (2001). Prescription Drug Abuse Prevention - Where Do We Go From Here? Alexandria, Va.: Community Antidrug Coalitions of America. [Full Text ]
Cooper, J., D. Czechowicz, S. Molinari, and R. Petersen (eds.) (1993). Impact of Prescription Drug Control Systems on Medical Practice and Patient Care, NIDA Research Monograph 131. Rockville, Md.: National Institute on Drug Abuse. [Full Text ]
Florida Department of Law Enforcement, Office of Statewide Intelligence (2001). Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida. Tallahassee, Fla.: Florida Department of Law Enforcement. [Full Text ]
Forgione, D., P. Neuenschwander, and T. Vermeer (2001). “Diversion of Prescription Drugs to the Black Market: What the States Are Doing to Curb the Tide.” Journal of Health Care Finance 27(4):65–78.
Fountain, J., P. Griffiths, M. Farrell, M. Gossop, and J. Strang (1997). “Diversion Tactics: How a Sample of Drug Misusers in Treatment Obtained Surplus Drugs to Sell on the Illicit Market.” International Journal of Drug Policy 9:159–167.
Goetz, K. (2001). “The OxyContin Pipeline: Multistate Network Keeps Appalachia Hooked, Cincinnati Part of ‘Near-Epidemic.’” Cincinnati Enquirer, February 25. [Full Text ]
Joranson, D., G. Carrow, K. Ryan, L. Schaefer, A. Gilson, P. Good, J. Eadie, S. Peine, and J. Dahl (2002). “Pain Management and Prescription Monitoring.” Journal of Pain and Symptom Management 23(3):231–238.
Kalb, C. (2001). “Playing With Pain Killers” Newsweek, April 9.
Middleton, H. (2000). “Electronically Transmitted Prescriptions – A Good Idea?” ThePharmaceutical Journal 265(7107):172–176. [Full Text ]
Mitka, M. (2000). “Abuse of Prescription Drugs: Is a Patient Ailing or Addicted?” JAMA: Journal of the American Medical Association 283(9):1126–1130.
National Association of Chain Drug Stores (2002). Community Pharmacy Projections.[Full Text ]
National Association of State Controlled Substances Authorities and Alliance of States With Prescription Monitoring Programs (2002). Prescription Monitoring Program Model Act. [Full Text ]
National Drug Intelligence Center (2001a). National Drug Threat Assessment 2002. [Full Text ]
——— (2001b). “OxyContin Diversion and Abuse.” Information Bulletin (January):1–6. [Full Text ]
——— (2000). National Drug Threat Assessment 2001: The Domestic Perspective. Johnstown, Pa.: U.S. Department of Justice, National Drug Intelligence Center. Also available at .[Full Text ]
National Drug Strategy Network (1996). “Prescription Dru g Abuse Rivals Illicit Dru g Abuse, Some See Double Standard in Law Enforcement.” New Briefs – Dru g Use Trends.. [Full Text ]
National Institute on Drug Abuse (2002). Prescription Drugs: Abuse and Addiction. Research Report Series. [Full Text ]
Palm Beach County Sheriff’s Department (2003). [Full Text ]
Payne, B., and D. Dabney (1997). “Prescription Fraud: Characteristics, Consequences, and Influences.” Journal of Drug Issues 27(4):807–820.
Purdue Pharma L.P. (2002). Purdue’s Antidiversion Efforts: Purdue Pharma’s 10-Point Plan to Reduce Prescription Drug Abuse and Diversion Without Compromising Patient Access to Proper Pain Control. Stamford, Conn.: Purdue Pharma L.P. [ Available through the Purdue Pharma L.P. Web Site ]
Ramer, P. (2001). Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida. Tallahassee, Fla.: Florida Department of Law Enforcement, Office of Statewide Intelligence. [Full Text ]
Schober, B. (2001). “Prescription Drug Fraud Steadily Rising.”
Substance Abuse and Mental Health Services Administration (2003). “Nonmedical Use of Prescription-Type Drugs Among Youths and Young Adults.” The NHSDA Report. Research Triangle Park, N.C.: Research Triangle Institute. [Full Text ]
——— (2002a). Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates, 1994–2001. Rockville, Md.: Department of Health and Human Services, Office of Applied Studies. [Full Text ]
“Emergency department trends from the Drug Abuse Warning Network, Final estimates, 1995-2002”
——— (2002b). Results From the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockville, Md.: U.S. Department of Health and Human Services, Office of Applied Studies. [Full Text ]
Texas Department of Public Safety (2000). Texas Prescription Program. Austin, Texas: Texas Department of Public Safety. [Full Text ]
UK Department of Health (1998). “Security of Prescription Forms.” National Health Service Circular 1998/062. [Full Text ]
——— (1997). “Alan Milburn Takes Direct Action Against #100M Prescription Fraud.” Press release, June 19.
U.S. Drug Enforcement Administration, Diversion Control Program (2000a). A Closer Look at State Prescription Monitoring Programs. Washington, D.C.: U.S. Drug Enforcement Administration. [Full Text ]
——— (2000b). “A Pharmacist’s Guide to Prescription Fraud.” Informational Brochures 1(1). [Full Text ]
——— (1999). “Don’t Be Scammed by a Drug Abuser.” Informational Brochures 1(1). [Full Text ]
——— (1998). Prescription Accountability Resource Guide. Washington D.C.: U.S. Drug Enforcement Administration.
U.S. General Accounting Office (2002). Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. Washington, D.C.: U.S. General Accounting Office. [Full Text ]
——— (1992). Prescription Drug Monitoring: States Can Readily Identify Illegal Sales and Use of Controlled Substances. Washington, D.C.: U.S. General Accounting Office. [Full Text ]
Wesson, D. and D. Smith (1990). “Prescription Drug Abuse.” Western Journal of Medicine 152(5):613–616. [Full Text ]
Wick, J. (1995). “Outsmarting Prescription Fraud.” Pharmacy Times 61 (April):33, 35–36.
Wilford, B. (1990). “Abuse of Prescription Drugs.” Addiction Medicine 152 (May):609–612.
Zickler, P. (2001). “NIDA Scientific Panel Reports on Prescription Drug Misuse and Abuse.” Research News, NIDA Notes 16(3) (August). [Full Text ]